{"meta":{"query_hash":"ca465dba2af2","filters":{"venue":"Exploration of Neuroprotective Therapy"},"cohort_total":10,"direct_labels_cover":0,"predictions_cover":10,"exported":10,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ca465dba2af2","api":"https://metacan.xera.ac/api/v1/cohort?venue=Exploration+of+Neuroprotective+Therapy"},"results":[{"id":"W4283719114","doi":"10.37349/ent.2022.00024","title":"Economics of dry needling and botulinum toxin type A for treatment of post-stroke spasticity: a review","year":2022,"lang":"en","type":"review","venue":"Exploration of Neuroprotective Therapy","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre for Interdisciplinary Research in Rehabilitation; Jewish Rehabilitation Hospital","funders":"","keywords":"Spasticity; Dry needling; Modified Ashworth scale; Stroke (engine); Botulinum toxin; Medicine; Physical therapy; Physical medicine and rehabilitation; Quality of life (healthcare); Randomized controlled trial; Surgery; Alternative medicine; Acupuncture","score_opus":0.1610981450012232,"score_gpt":0.35395577675145257,"score_spread":0.19285763175022938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283719114","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020075099,0.99940383,0.00003135462,0.000104257655,0.00003916872,0.000016975615,0.00003600053,0.0000010385029,0.00016664458],"genre_scores_gemma":[0.0021465595,0.9974746,0.00009396903,0.00012118425,0.000063112006,0.000027791524,0.00002791499,9.674263e-7,0.000043845554],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844956,0.00050472055,0.0004475555,0.00013024246,0.00038855785,0.00007925457],"domain_scores_gemma":[0.9916049,0.0066860593,0.0011141085,0.000050007784,0.0004723,0.00007262682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002920874,0.0012238835,0.0047856783,0.006864552,0.0002743597,0.0018741033,0.0012923824,0.0015320049,0.004316667],"category_scores_gemma":[0.009213774,0.00061711913,0.0036583776,0.0068369554,0.00041637025,0.0016023108,0.00072344113,0.0008849242,0.00030394056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008588929,0.00013736266,0.0007012761,0.567665,0.0047685523,0.00020014873,0.00007848184,0.00097626087,0.0002088206,0.0026537233,0.009225774,0.4125257],"study_design_scores_gemma":[0.00075976143,0.0011326055,0.009743482,0.699204,0.035895083,0.002284307,0.00036615686,0.0008469712,0.00035237314,0.004916965,0.24439155,0.00010668299],"about_ca_topic_score_codex":0.003976107,"about_ca_topic_score_gemma":0.0052390527,"teacher_disagreement_score":0.006864552,"about_ca_system_score_codex":0.0026903385,"about_ca_system_score_gemma":0.0031636276,"threshold_uncertainty_score":0.019519925},"labels":[],"label_agreement":null},{"id":"W4382776780","doi":"10.37349/ent.2023.00045","title":"Muscle fatigue and exercise-related biomarkers in amyotrophic lateral sclerosis","year":2023,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Amyotrophic lateral sclerosis; Medicine; Physical medicine and rehabilitation; Muscle fatigue; Mechanism (biology); Neuroinflammation; Quality of life (healthcare); Physical therapy; Neuroscience; Inflammation; Disease; Internal medicine; Electromyography; Psychology","score_opus":0.1278787606952983,"score_gpt":0.32479994822459635,"score_spread":0.19692118752929805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382776780","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031754738,0.99496967,0.0004406865,0.0004903096,0.00017141597,0.000007658381,0.000051134062,0.0000069689204,0.00068657997],"genre_scores_gemma":[0.062369164,0.9322303,0.0017742617,0.0010164755,0.00096288737,0.00005827341,0.00021071956,0.000003979588,0.0013740191],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997485,0.00008431371,0.000047240534,0.00003806919,0.00006283723,0.000019122357],"domain_scores_gemma":[0.9996569,0.00015045702,0.00009176122,0.000005913872,0.00007925618,0.000015763348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006709542,0.00045815847,0.0007938653,0.0013303815,0.00012947542,0.00065284764,0.00027429563,0.0007785329,0.0007936973],"category_scores_gemma":[0.00086842023,0.00011764291,0.00043386282,0.00093477865,0.00027278092,0.0005630634,0.0003094247,0.0006348372,0.00023656285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009487704,0.00021981943,0.01445596,0.03144105,0.0008035126,0.0015461531,0.00057854864,0.0008590239,0.018129738,0.0040939553,0.015747173,0.9111763],"study_design_scores_gemma":[0.00018866923,0.0032457027,0.16057372,0.021528875,0.0025642402,0.020854192,0.0012381914,0.0018965267,0.017951757,0.01718178,0.7525106,0.0002657632],"about_ca_topic_score_codex":0.00067430525,"about_ca_topic_score_gemma":0.0011056213,"teacher_disagreement_score":0.0013303815,"about_ca_system_score_codex":0.00030777504,"about_ca_system_score_gemma":0.00034169483,"threshold_uncertainty_score":0.0035483837},"labels":[],"label_agreement":null},{"id":"W4386164566","doi":"10.37349/ent.2023.00047","title":"Diffusion magnetic resonance imaging-based surrogate marker in amyotrophic lateral sclerosis","year":2023,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":4,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Japan Society for the Promotion of Science; Promotion and Mutual Aid Corporation for Private Schools of Japan","keywords":"Diffusion MRI; Amyotrophic lateral sclerosis; Magnetic resonance imaging; Surrogate endpoint; Medicine; Neuroscience; Multiple sclerosis; Pathology; Disease; Radiology; Psychology","score_opus":0.07204763177714238,"score_gpt":0.30176038986256315,"score_spread":0.22971275808542077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386164566","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30006722,0.4957137,0.1762428,0.004961852,0.0014399727,0.0006165089,0.0026130981,0.00074060756,0.017604316],"genre_scores_gemma":[0.8053889,0.10194824,0.08360024,0.00091916334,0.0008097081,0.0007712868,0.0019618694,0.00008591505,0.0045145764],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983789,0.00083203183,0.00021997967,0.00014239384,0.00037461487,0.000052065654],"domain_scores_gemma":[0.99816835,0.0005850904,0.00065752,0.000108828564,0.00035606857,0.00012413687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039128195,0.0007289446,0.0012177345,0.0015030068,0.00027586264,0.0013032258,0.0005158404,0.00084404217,0.00065571227],"category_scores_gemma":[0.004749796,0.0001556454,0.00039154704,0.0014664779,0.0005925586,0.00077999645,0.00071796065,0.0011224251,0.00045184314],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075506372,0.0007566352,0.17350042,0.00804649,0.0014350925,0.0052561606,0.0009012616,0.008980631,0.15420727,0.024887271,0.013100086,0.601378],"study_design_scores_gemma":[0.00075629214,0.013865065,0.37429237,0.0063105384,0.0025714505,0.041957017,0.0016132846,0.061713815,0.1633952,0.06364469,0.26903474,0.0008454357],"about_ca_topic_score_codex":0.0009946233,"about_ca_topic_score_gemma":0.0011041447,"teacher_disagreement_score":0.0039128195,"about_ca_system_score_codex":0.00048981275,"about_ca_system_score_gemma":0.0007471916,"threshold_uncertainty_score":0.020693243},"labels":[],"label_agreement":null},{"id":"W4388096027","doi":"10.37349/ent.2023.00053","title":"Aldh1a1 and additional markers of dopamine cell heterogeneity in substantia nigra and ventral tegmental area identified as preserved in two transgenic α-synuclein mouse models of neurodegenerative disease","year":2023,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Substantia nigra; Dopamine; Ventral tegmental area; Dopamine transporter; Tyrosine hydroxylase; Pars compacta; Biology; Midbrain; Neuroscience; Vesicular monoamine transporter 2; Neurodegeneration; Vesicular monoamine transporter; Cell biology; Monoamine neurotransmitter; Dopaminergic; Internal medicine; Central nervous system; Genetics; Medicine; Serotonin; Disease","score_opus":0.06304840872514157,"score_gpt":0.2938665998782729,"score_spread":0.23081819115313135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388096027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99191064,0.0014708533,0.0046067717,0.000076412274,0.00002662368,0.000034934015,0.00044561902,0.00012000354,0.0013081392],"genre_scores_gemma":[0.98260075,0.0011352677,0.0077757277,0.00006943496,0.000013259428,0.00014450884,0.0015327759,0.00005595668,0.00667239],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996718,0.000022466487,0.000035455076,0.00011632358,0.00009155428,0.00006236348],"domain_scores_gemma":[0.99975675,0.00001732424,0.000096117314,0.000020442576,0.000035148816,0.00007426727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024537113,0.0005398068,0.0003457369,0.0016361652,0.0002490546,0.00046078465,0.00031402303,0.0005486259,0.0016324407],"category_scores_gemma":[0.00011826366,0.0003964191,0.00032805905,0.0002900939,0.00039672948,0.0002818056,0.00029765436,0.0007044241,0.00028937845],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010595675,0.000026183401,0.0005243907,0.000027487404,0.000010677347,0.000108006076,0.000034308992,0.000018704566,0.998555,0.00006905839,0.000013738492,0.00050641707],"study_design_scores_gemma":[0.00006305483,0.00075923925,0.061100304,0.000021847161,0.00015063104,0.004311153,0.00016725603,0.001469024,0.9287335,0.0002379222,0.0029659185,0.000020000341],"about_ca_topic_score_codex":0.0006770839,"about_ca_topic_score_gemma":0.0015584603,"teacher_disagreement_score":0.0016361652,"about_ca_system_score_codex":0.0003309027,"about_ca_system_score_gemma":0.00017206861,"threshold_uncertainty_score":0.0054610968},"labels":[],"label_agreement":null},{"id":"W4388205557","doi":"10.37349/ent.2023.00051","title":"Cognitive recovery in psychiatric disorders: transdiagnostic interdisciplinary intervention in a high intensity partial psychiatric in-patient unit","year":2023,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychoeducation; Brief Psychiatric Rating Scale; Psychology; Global Assessment of Functioning; Cognition; Clinical psychology; Rating scale; Psychiatry; Montreal Cognitive Assessment; Hamilton Anxiety Rating Scale; Montgomery–Åsberg Depression Rating Scale; Psychological intervention; Anxiety; Major depressive disorder; Psychosis; Cognitive impairment; Developmental psychology","score_opus":0.047132491217081025,"score_gpt":0.33943986354115907,"score_spread":0.29230737232407805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388205557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932194,0.00018357793,0.000088238965,0.000059407794,0.000010741825,0.00008616466,0.000021745507,0.000004455793,0.00022383072],"genre_scores_gemma":[0.99856985,0.00027631328,0.00046117106,0.00015327711,0.000046488007,0.00015573959,0.00013068694,0.0000013296909,0.00020509944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997415,0.00008707915,0.000018130853,0.00003093801,0.000026209687,0.00009611319],"domain_scores_gemma":[0.99936825,0.00003314073,0.000120284734,0.000020775085,0.00003126971,0.0004263167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027765083,0.00026964312,0.0003178074,0.00032149538,0.0008922954,0.0003017451,0.00038588842,0.00031013082,0.0014692582],"category_scores_gemma":[0.0008413558,0.00012251607,0.00038019012,0.00023317274,0.00023939088,0.00015629873,0.00091578264,0.0004792066,0.00017909762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011999237,0.049231358,0.62560505,0.0010321778,0.00039126532,0.0033633907,0.0035350625,0.0008170293,0.011265395,0.00013692278,0.0029367635,0.28968635],"study_design_scores_gemma":[0.0010680855,0.016361168,0.9769627,0.00009590902,0.00009476082,0.001299187,0.0018435618,0.00045795296,0.0006602457,0.000059858394,0.0010737655,0.000022713744],"about_ca_topic_score_codex":0.0022658026,"about_ca_topic_score_gemma":0.0054973345,"teacher_disagreement_score":0.0022658026,"about_ca_system_score_codex":0.000727228,"about_ca_system_score_gemma":0.0013135275,"threshold_uncertainty_score":0.005276382},"labels":[],"label_agreement":null},{"id":"W4408266567","doi":"10.37349/ent.2024.100498","title":"Multilayered neuroprotection by cannabinoids in neurodegenerative diseases","year":2025,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuroprotection; Neuroscience; Medicine; Pharmacology; Biology","score_opus":0.026623808582830186,"score_gpt":0.3216783508391937,"score_spread":0.2950545422563635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408266567","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022741606,0.96767473,0.002324626,0.00095506967,0.00028176449,0.000028873601,0.00008743686,0.000044961147,0.0058609396],"genre_scores_gemma":[0.13238315,0.8602468,0.0032993893,0.0005368144,0.00033183873,0.00002863074,0.0000880169,0.000007177228,0.003078149],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99989164,0.00001926098,0.000013798876,0.000019945564,0.000033265074,0.000022010621],"domain_scores_gemma":[0.99995506,0.000009046543,0.00000925613,0.0000026974615,0.000014286986,0.000009552958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021065958,0.00038020988,0.00050532166,0.00088639715,0.00028927336,0.0005328237,0.00028250422,0.00044023554,0.0010857065],"category_scores_gemma":[0.00013415674,0.00009998846,0.0002870669,0.00044487647,0.00038097563,0.0004544866,0.00056116923,0.000642256,0.00021592449],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082624203,0.00014731218,0.0012872677,0.013338191,0.00031325998,0.0020673473,0.0005569427,0.0010356067,0.30844763,0.02714534,0.006001073,0.6388338],"study_design_scores_gemma":[0.00012136826,0.0016215033,0.023045823,0.004840409,0.00081049185,0.008537228,0.00072301,0.0013087052,0.15256162,0.031506673,0.7747802,0.00014297117],"about_ca_topic_score_codex":0.0014781106,"about_ca_topic_score_gemma":0.004229344,"teacher_disagreement_score":0.0014781106,"about_ca_system_score_codex":0.00052320387,"about_ca_system_score_gemma":0.00061880186,"threshold_uncertainty_score":0.0037961602},"labels":[],"label_agreement":null},{"id":"W4408267256","doi":"10.37349/ent.2025.100498","title":"Multilayered neuroprotection by cannabinoids in neurodegenerative diseases","year":2025,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuroprotection; Neurodegeneration; Neuroscience; Endocannabinoid system; Excitotoxicity; Neuroinflammation; Context (archaeology); Medicine; Oxidative stress; Pharmacology; Psychology; Biology; Inflammation; Disease; Internal medicine; Glutamate receptor","score_opus":0.026623808582830186,"score_gpt":0.3216783508391937,"score_spread":0.2950545422563635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408267256","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022741606,0.96767473,0.002324626,0.00095506967,0.00028176449,0.000028873601,0.00008743686,0.000044961147,0.0058609396],"genre_scores_gemma":[0.13238315,0.8602468,0.0032993893,0.0005368144,0.00033183873,0.00002863074,0.0000880169,0.000007177228,0.003078149],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99989164,0.00001926098,0.000013798876,0.000019945564,0.000033265074,0.000022010621],"domain_scores_gemma":[0.99995506,0.000009046543,0.00000925613,0.0000026974615,0.000014286986,0.000009552958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021065958,0.00038020988,0.00050532166,0.00088639715,0.00028927336,0.0005328237,0.00028250422,0.00044023554,0.0010857065],"category_scores_gemma":[0.00013415674,0.00009998846,0.0002870669,0.00044487647,0.00038097563,0.0004544866,0.00056116923,0.000642256,0.00021592449],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082624203,0.00014731218,0.0012872677,0.013338191,0.00031325998,0.0020673473,0.0005569427,0.0010356067,0.30844763,0.02714534,0.006001073,0.6388338],"study_design_scores_gemma":[0.00012136826,0.0016215033,0.023045823,0.004840409,0.00081049185,0.008537228,0.00072301,0.0013087052,0.15256162,0.031506673,0.7747802,0.00014297117],"about_ca_topic_score_codex":0.0014781106,"about_ca_topic_score_gemma":0.004229344,"teacher_disagreement_score":0.0014781106,"about_ca_system_score_codex":0.00052320387,"about_ca_system_score_gemma":0.00061880186,"threshold_uncertainty_score":0.0037961602},"labels":[],"label_agreement":null},{"id":"W4413407181","doi":"10.37349/ent.2025.1004113","title":"Cognitive and neuropsychiatric outcomes in economically active young patients with epilepsy: a case-control study from a secondary medical center in Mexico","year":2025,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epilepsy; Center (category theory); Cognition; Psychiatry; Medicine; Psychology","score_opus":0.017152175187691205,"score_gpt":0.29483283748458294,"score_spread":0.27768066229689176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413407181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997162,0.00006129586,0.00002031484,0.0000119853785,0.0000016799781,0.000009285878,0.00006508987,6.9893395e-7,0.000113355185],"genre_scores_gemma":[0.9996105,0.00008365936,0.00003304564,0.000021765874,0.0000064349133,0.000012816358,0.00015638003,5.537334e-7,0.00007488934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997708,0.00003642833,0.000029109999,0.00007366294,0.00003816659,0.00005188582],"domain_scores_gemma":[0.9996018,0.000053062522,0.0002062579,0.000032330725,0.00004683707,0.000059755803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036901527,0.000332642,0.0004138247,0.0010651398,0.0010568298,0.0005370478,0.00034298986,0.00039925723,0.0012324267],"category_scores_gemma":[0.00071611296,0.00027471985,0.0003009051,0.00083570485,0.00031165226,0.0002291064,0.0004106138,0.00025076946,0.00012479917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007088752,0.00008810282,0.99856734,0.0000087047365,0.000023925464,0.00040952084,0.00017649347,0.0000053919466,0.00013405779,0.000009833047,0.000050669725,0.00045495134],"study_design_scores_gemma":[0.000017474882,0.00012603747,0.99858034,0.0000065200356,0.000028479595,0.0005526087,0.00048590807,0.000043923512,0.00002667365,0.0000064688456,0.00012350272,0.0000021168123],"about_ca_topic_score_codex":0.016403155,"about_ca_topic_score_gemma":0.020074349,"teacher_disagreement_score":0.016403155,"about_ca_system_score_codex":0.00057704444,"about_ca_system_score_gemma":0.000404798,"threshold_uncertainty_score":0.032615364},"labels":[],"label_agreement":null},{"id":"W4415719656","doi":"10.37349/ent.2025.1004119","title":"Gene therapy for Parkinson’s disease: a new frontier in neurodegenerative diseases","year":2025,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Genetic enhancement; Disease; Neurotrophic factors; Clinical trial; Dopaminergic; Adeno-associated virus; Parkinson's disease; Substantia nigra; Gene delivery","score_opus":0.06816881841313126,"score_gpt":0.31457498325796396,"score_spread":0.2464061648448327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415719656","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000605218,0.9945834,0.0012661583,0.0016173105,0.0005741064,0.0000075433018,0.000011443309,0.00002073691,0.0013139684],"genre_scores_gemma":[0.0033449028,0.9932706,0.0010900986,0.0006612882,0.0006878878,0.000013510325,0.00002274769,0.000007327993,0.00090159755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974626,0.00006601492,0.000022359638,0.00004259855,0.00009722723,0.000025427104],"domain_scores_gemma":[0.99973184,0.00014672766,0.000026374699,0.000009999542,0.000056874294,0.000028274017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077561376,0.0004901925,0.0010897295,0.0008667314,0.00028250905,0.0012189158,0.000446731,0.0011463026,0.0015257921],"category_scores_gemma":[0.0004941633,0.0001384686,0.000354983,0.0007806122,0.00096129754,0.0019019672,0.00056856126,0.0020283253,0.0007822429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000182859,0.00014658103,0.00029904154,0.012244881,0.00007318745,0.0005755692,0.00034112326,0.0005759986,0.030061148,0.03192099,0.03165604,0.8919227],"study_design_scores_gemma":[0.000032542845,0.00041725414,0.00076105987,0.0022747598,0.000068657995,0.0018748926,0.00013094972,0.000291099,0.0043382873,0.011079626,0.9786977,0.000033209133],"about_ca_topic_score_codex":0.0003857803,"about_ca_topic_score_gemma":0.00074975396,"teacher_disagreement_score":0.0015257921,"about_ca_system_score_codex":0.00054520596,"about_ca_system_score_gemma":0.0007173803,"threshold_uncertainty_score":0.0051043034},"labels":[],"label_agreement":null},{"id":"W7117305064","doi":"10.37349/ent.2025.1004133","title":"Can we find early phase biomarkers for ALS: What are the prospects and challenges?","year":2025,"lang":"en","type":"article","venue":"Exploration of Neuroprotective Therapy","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capilano University; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Disease; Biomarker; Disease treatment; Stage (stratigraphy); Precision medicine","score_opus":0.15187095276932172,"score_gpt":0.36434119080316607,"score_spread":0.21247023803384435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117305064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032566434,0.6104254,0.013836325,0.35674855,0.008423644,0.00016116482,0.00071169395,0.00037158138,0.0060649686],"genre_scores_gemma":[0.050029412,0.7427288,0.054115374,0.1123894,0.026834697,0.0009125631,0.0016641173,0.00027702944,0.011048646],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9949378,0.001927695,0.0004905388,0.0006853216,0.0013155515,0.0006430245],"domain_scores_gemma":[0.9515662,0.023895154,0.0031889037,0.002515239,0.014931518,0.0039029666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033062197,0.0019086048,0.004081145,0.0030441398,0.0016657098,0.010020332,0.004504515,0.012736605,0.017615922],"category_scores_gemma":[0.049016148,0.001057694,0.0026301662,0.0018682051,0.0065054223,0.024300946,0.003882521,0.012231845,0.009824878],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013590677,0.0007528224,0.009096985,0.0066433144,0.0005578978,0.0008954398,0.0005060157,0.0015745598,0.004071276,0.042344224,0.18630815,0.7458902],"study_design_scores_gemma":[0.00035547683,0.0014254564,0.0065749325,0.015435056,0.00079863466,0.0016653056,0.005275719,0.0029825028,0.0037119333,0.22673187,0.73460346,0.00043964907],"about_ca_topic_score_codex":0.0028700093,"about_ca_topic_score_gemma":0.0044385646,"teacher_disagreement_score":0.033062197,"about_ca_system_score_codex":0.0022742979,"about_ca_system_score_gemma":0.010430907,"threshold_uncertainty_score":0.17485172},"labels":[],"label_agreement":null}]}